Skip to main content

Table 2 Respiratory function indices in patients with CTEPH

From: Vascular involvement in chronic thromboembolic pulmonary hypertension is associated with spirometry obstructive impairment

 

Measured values

Expected values

p value

VC (L)

2.55 (2.05–3.07)

2.57 (2.33–2.92)

< 0.001**

%VC

94.8 (83.1–101.7)

  

FVC (L)

2.55 (1.98–3.00)

2.48 (2.26–2.83)

< 0.001**

%FVC

94.6 (84.2–105.1)

  

FEV1.0 (L)

1.91 (1.47–2.32)

2.04 (1.82–2,46)

< 0.001**

FEV1.0/FVC (%)

76.0 (70.0–82.1)

81.9 (79.3–85.9)

< 0.001**

%FEV1.0

83.6 (73.8–98.3)

  

MMF (L)

1.40 (0.87–2.17)

2.60 (2.30–3.10)

< 0.001**

%MMF

48.9 (35.1–71.6)

  

\({\dot{\text{V}}}\)50

2.02 (1.28–2.75)

2.95 (2.66–3.5)

< 0.001**

%\({\dot{\text{V}}}\)50

59.9 (42.9–82.6)

  

\({\dot{\text{V}}}\)25 (L)

0.47 (0.29–0.82)

1.06 (0.87–1.39)

< 0.001**

%\({\dot{\text{V}}}\)25

41.8 (29.0–58.5)

  

PEF (L/s)

5.54 (4.42–6.67)

5.62 (5.37–6.08)

< 0.001**

> 5% of ATI, n (%)

24 (17.8%)

  

Restrictive ventilatory impairment, n (%)

22 (16.3%)

  

Obstructive ventilatory impairment, n (%)

34 (25.2%)

  

Mixed ventilatory impairment, n (%)

3 (2.2%)

  

DLco (mL/min/mmHg)

13.1 (10.9–16.0)

17.0 (15.1–20.1)

< 0.001**

%DLco

77.0 (64.8–86.5)

  

TLC (L)

4.77 (3.92–5.64)

4.44 (4.11–4.97)

N.S

RV (L)

1.86 (1.58–2.24)

1.82 (1.69–1.96)

N.S

RV/TLC (%)

39.9 (35.4–43.9)

  
  1. Values are expressed as the median with the interquartile range
  2. VC, vital capacity; FEV1.0, forced expiratory volume in 1 second; FVC, forced vital capacity; MMF, maximal mid‒expiratory flow; \({\dot{\text{V}}}\)50 and \({\dot{\text{V}}}\)25, flow at 50,and 25% of vital capacity; PEF, peak expiratory flow; ATI, air trapping index; DLco, diffused capacity of carbon monoxide; TLC, total lung capacity; RV, residual volume
  3. **p < 0.01